LLY

765.29

-0.98%↓

JNJ

176.29

-0.52%↓

ABBV

221.49

+0.96%↑

UNH

344.26

+1.28%↑

AZN

76.43

-1.87%↓

LLY

765.29

-0.98%↓

JNJ

176.29

-0.52%↓

ABBV

221.49

+0.96%↑

UNH

344.26

+1.28%↑

AZN

76.43

-1.87%↓

LLY

765.29

-0.98%↓

JNJ

176.29

-0.52%↓

ABBV

221.49

+0.96%↑

UNH

344.26

+1.28%↑

AZN

76.43

-1.87%↓

LLY

765.29

-0.98%↓

JNJ

176.29

-0.52%↓

ABBV

221.49

+0.96%↑

UNH

344.26

+1.28%↑

AZN

76.43

-1.87%↓

LLY

765.29

-0.98%↓

JNJ

176.29

-0.52%↓

ABBV

221.49

+0.96%↑

UNH

344.26

+1.28%↑

AZN

76.43

-1.87%↓

Search

Talphera Inc.

Abrir

0.91 -3.19

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.85

Máximo

0.94

Indicadores-chave

By Trading Economics

Funcionários

13

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+206.12% upside

Dividendos

By Dow Jones

Próximos Ganhos

12 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

9.5M

17M

Abertura anterior

4.1

Fecho anterior

0.91

Talphera Inc. Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de set. de 2025, 23:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid -- Update

17 de set. de 2025, 22:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid

17 de set. de 2025, 21:59 UTC

Ganhos

Cryptocurrency-Exchange Bullish Swings to Profit in First Report as Public Company

17 de set. de 2025, 23:44 UTC

Conversa de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

17 de set. de 2025, 23:39 UTC

Conversa de Mercado

Gold Rises Amid Prospects of Further Fed Rate Cuts -- Market Talk

17 de set. de 2025, 22:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Santos: XRG Consortium Wouldn't Agree to Appropriate Risk Allocation Between It and Santos Shareholders

17 de set. de 2025, 22:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Santos: XRG Consortium Wouldn't Agree to Acceptable Terms That Protected Value of Transaction

17 de set. de 2025, 22:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Santos Had Expressed Concern to XRG Consortium About Delays in Agreeing to Scheme Implementation Agreement

17 de set. de 2025, 22:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Santos: Consortium Notified Board of Decision to Withdraw Proposal on Weds Evening

17 de set. de 2025, 22:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Santos Confirms XRG Consortium Has Withdrawn Takeover Proposal

17 de set. de 2025, 21:00 UTC

Ganhos

Darden Restaurants to Report Earnings. Why the Olive Garden Parent Is Expected to Stay Strong. -- Barrons.com

17 de set. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

17 de set. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de set. de 2025, 19:59 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de set. de 2025, 19:59 UTC

Conversa de Mercado

Treasury Yields, Dollar Rise as Fed Cuts, Powell Warns of Risks -- Market Talk

17 de set. de 2025, 19:07 UTC

Conversa de Mercado

Oil Futures Snap Three-Session Winning Streak -- Market Talk

17 de set. de 2025, 18:43 UTC

Conversa de Mercado

Treasury Yields, Dollar Reverse Course as Powell Talks to Reporters -- Market Talk

17 de set. de 2025, 18:38 UTC

Conversa de Mercado

U.S. Natural Gas Futures Mixed Ahead of Storage Data -- Market Talk

17 de set. de 2025, 18:20 UTC

Conversa de Mercado

Gold Dips After Quarter-Point Rate Cut -- Market Talk

17 de set. de 2025, 18:18 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de set. de 2025, 18:18 UTC

Conversa de Mercado

Treasury Yields, Dollar Fall on Nearly Unanimous Fed Cut -- Market Talk

17 de set. de 2025, 18:14 UTC

Conversa de Mercado

Oil Slips Some More as Fed Makes Expected 25 Bp Rate Cut -- Market Talk

17 de set. de 2025, 17:59 UTC

Conversa de Mercado

Soyoil Takes Hit as Traders Consider EPA Proposal -- Market Talk

17 de set. de 2025, 17:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix 'Has Won The Streaming Wars,' Analyst Says. The Stock Is a Buy. -- Barrons.com

17 de set. de 2025, 17:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Walmart Stock Heads for a Record High. The Retailer Could Become a Leader in 'Agentic' AI. -- Barrons.com

17 de set. de 2025, 16:51 UTC

Ganhos

Correct: Exor 1H Net Loss -EUR624M

17 de set. de 2025, 16:34 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de set. de 2025, 16:34 UTC

Conversa de Mercado

Bank of Canada Ditches Resilience Talk, Plays Up Slowing Growth -- Market Talk

17 de set. de 2025, 16:25 UTC

Ganhos

Wolters Kluwer: July, August Saw a Slight Increase in Organic Growth Compared to 1H

17 de set. de 2025, 16:23 UTC

Ganhos

Wolters Kluwer: Year-to-Date Performance In Line With 2025 Guidance

Comparação entre Pares

Variação de preço

Talphera Inc. Previsão

Preço-alvo

By TipRanks

206.12% parte superior

Previsão para 12 meses

Média 3 USD  206.12%

Máximo 3 USD

Mínimo 3 USD

Com base em 1 analistas de Wall Street que oferecem metas de preço de 12 meses para Talphera Inc. - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

1 ratings

1

Comprar

0

Manter

0

Vender

Informação Financeira

$

Sobre Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.
help-icon Live chat